Catabasis Pharma chief business officer resigns
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Catabasis Pharmaceuticals Inc. said Chief Business Officer Rick Modi will leave the company, effective Feb. 10, to pursue a new opportunity.
Modi joined Catabasis in February 2015. Prior to joining the company, Modi was senior vice president of global marketing at InterMune, an orphan drug company acquired by Roche in 2014.